How to manage the revision of cGMPs Annex 01 for sterile products
Panel DiscussionHow to manage the revision of cGMPs Annex 01 for sterile products
2025-06-04 | 02:15 PM - 02:30 PM | TPD Room
Information
Following the presentations by our expert speakers Andrea Salmaso, Martina Cavenaghi, Christian Hilscher, and Varadharaj Vijayakumar, along with insights from Zahra Halvorsen — who will also serve as the moderator of the upcoming panel discussion — the session will transition into an interactive panel discussion exploring the implications of the revised Annex 1 for sterile products.
This dynamic conversation will bring together diverse perspectives from industry experts to address key challenges and practical approaches to implementing the updated regulations. Panelists will examine interpretation strategies, compliance pathways, and the impact of these changes on manufacturing processes and quality systems. Attendees will have the opportunity to engage with speakers through a Q&A session, fostering collaborative dialogue around best practices and effective solutions for navigating the revised Annex 1 requirements in sterile pharmaceutical production.
